Skip to content

Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours

Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06540846
Acronym
STUMP
Enrollment
392
Registered
2024-08-06
Start date
2023-12-01
Completion date
2026-12-31
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stump

Keywords

algorithm, diagnostic, pronostic

Brief summary

Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.

Interventions

OTHERNo intervention

No intervention since this is an observational study

Sponsors

Institut Bergonié
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyosarcomas), registered in the RRePS database and/or treated at Institut Bergonié or one of the participating centers. * Histopathological material available (kerosene blocks and/or slides). * The follow-up (outcome) is required for each LMS/ STUMP.

Exclusion criteria

* na

Design outcomes

Primary

MeasureTime frameDescription
Develop deep learning models that can accurately subclassify gynaecologic smooth muscle tumoursthroughout the conduct of the study - an expected average of 6 months after data collectionThis project aims to improve the diagnosis and prognosis of gynecologic smooth muscle tumors, including leiomyomas (LM), leiomyosarcomas (LMS), and smooth muscle tumors of uncertain malignant potential (STUMP). In detail, a workflow comprising 2 stages will be developed to automatically classify GSMT subtypes from whole-slide images and to predict progression-free survival for patients in the LMS and STUMP groups, thereby providing clinicians with a more effective tool to improve workflow quality.

Secondary

MeasureTime frameDescription
Develop a prognostic tool for STUMP6 months after receiving the data.Develop a model to predict progression-free survival for STUMP group based on the features extracted from Whole Slide Images.

Countries

France

Contacts

Primary ContactSabrina CROCE
s.croce@bordeaux.unicancer.fr+33556333333

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026